Heilongjiang ZBD Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.039x

Heilongjiang ZBD Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Heilongjiang ZBD Pharmaceutical Co Ltd (603567) has a cash flow conversion efficiency ratio of 0.039x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥283.54 Million ≈ $41.49 Million USD) by net assets (CN¥7.29 Billion ≈ $1.07 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Heilongjiang ZBD Pharmaceutical Co Ltd (2011–2025)

Cash flow conversion efficiency of Heilongjiang ZBD Pharmaceutical Co Ltd from 2011 to 2025. This chart illustrates how Heilongjiang ZBD Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Heilongjiang ZBD Pharmaceutical Co Ltd for real-time trading data and today's change.

Heilongjiang ZBD Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Heilongjiang ZBD Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Heilongjiang ZBD Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Heilongjiang ZBD Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see how much is Heilongjiang ZBD Pharmaceutical Co Ltd worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Shanghai Kinetic Medical Co SHE:300326	0.025x
MA Financial Group Ltd AU:MAF	0.847x
Tropicana Corporation Bhd KLSE:5401	0.088x
Steel Partners Holdings LP NYSE:SPLP	-0.004x
Tianjin Jingwei Electric Wire Co Ltd SHE:300120	0.053x
YIT Oyj HE:YIT	-0.034x
CK Power Public Company Limited BK:CKP-R	0.022x
HMT Limited NSE:HMT	-0.004x

Annual Cash Flow Conversion Efficiency for Heilongjiang ZBD Pharmaceutical Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Heilongjiang ZBD Pharmaceutical Co Ltd from 2011 to 2025. Review cash generation quality of Heilongjiang ZBD Pharmaceutical Co Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥6.28 Billion ≈ $918.84 Million	CN¥322.10 Million ≈ $47.13 Million	0.051x	+158.84%
2024-12-31	CN¥8.29 Billion ≈ $1.21 Billion	CN¥164.31 Million ≈ $24.04 Million	0.020x	+134.80%
2023-12-31	CN¥8.04 Billion ≈ $1.18 Billion	CN¥-457.90 Million ≈ $-67.00 Million	-0.057x	-23.85%
2022-12-31	CN¥7.11 Billion ≈ $1.04 Billion	CN¥-326.79 Million ≈ $-47.82 Million	-0.046x	+25.28%
2021-12-31	CN¥7.05 Billion ≈ $1.03 Billion	CN¥-433.94 Million ≈ $-63.50 Million	-0.062x	-318.25%
2020-12-31	CN¥5.50 Billion ≈ $805.28 Million	CN¥155.18 Million ≈ $22.71 Million	0.028x	-32.99%
2019-12-31	CN¥5.25 Billion ≈ $768.26 Million	CN¥220.92 Million ≈ $32.33 Million	0.042x	-42.93%
2018-12-31	CN¥4.98 Billion ≈ $729.21 Million	CN¥367.40 Million ≈ $53.76 Million	0.074x	-59.57%
2017-12-31	CN¥4.68 Billion ≈ $684.71 Million	CN¥853.19 Million ≈ $124.85 Million	0.182x	+4862.02%
2016-12-31	CN¥4.31 Billion ≈ $630.20 Million	CN¥15.83 Million ≈ $2.32 Million	0.004x	+104.52%
2015-12-31	CN¥3.98 Billion ≈ $582.63 Million	CN¥-323.90 Million ≈ $-47.40 Million	-0.081x	-145.75%
2014-12-31	CN¥2.17 Billion ≈ $317.92 Million	CN¥386.32 Million ≈ $56.53 Million	0.178x	+77.83%
2013-12-31	CN¥1.75 Billion ≈ $255.64 Million	CN¥174.68 Million ≈ $25.56 Million	0.100x	-14.48%
2012-12-31	CN¥1.32 Billion ≈ $193.04 Million	CN¥154.25 Million ≈ $22.57 Million	0.117x	+3.07%
2011-12-31	CN¥923.09 Million ≈ $135.08 Million	CN¥104.71 Million ≈ $15.32 Million	0.113x	--

About Heilongjiang ZBD Pharmaceutical Co Ltd

SHG:603567 China Drug Manufacturers - Specialty & Generic

Market Cap

$689.31 Million

CN¥4.71 Billion CNY

Market Cap Rank

#10294 Global

#2721 in China

Share Price

CN¥5.01

Change (1 day)

-1.38%

52-Week Range

CN¥4.28 - CN¥11.70

All Time High

CN¥28.17